Nebius Group NV vs GeneDx Holdings Corp — how do they compare? Nebius Group NV trades at $219.32 (market cap $46.37B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Nebius Group NV is far larger — about 25.8× GeneDx Holdings Corp's market cap, and Nebius Group NV is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| NBIS | WGS | |
|---|---|---|
Market Cap | $46.37B | $1.80B |
Sector | Technology | Technology |
52-Week High | $286.69 | $167.51 |
52-Week Low | $50.40 | $34.51 |
Enterprise Value | $46.56B | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →